Internal Medicine

Leukemia

Questions discussed in this category

How do you approach management of a patient with mast cell leukemia?

Do you typically use avapritinib? If you do, what dose do you typically start at?

1 Answer available

What is your preferred frontline treatment for CLL in young patients < 50 years old?

5 Answers available

Papers discussed in this category

The New England journal of medicine, 2025 Feb 05

Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia.

Cancers, 2021 Jun 23

Chemoimmunotherapy in the First-Line Treatment of Chronic Lymphocytic Leukaemia: Dead Yet, or Alive and Kicking?

Seminars in hematology, 2023 Dec 26

B-cell receptor immunoglobulin stereotypy in chronic lymphocytic leukemia: Key to understanding disease biology and stratifying patients.

Haematologica, 2020 Nov 01

Prognostic impact of prevalent chronic lymphocytic leukemia stereotyped subsets: analysis within prospective clinical trials of the German CLL Study Group (GCLLSG).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2024 Dec 07

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease.

The New England journal of medicine, 2016-06-30

Efficacy and Safety of Midostaurin in Advanced Systemic Mastocytosis.

Nature medicine, 2021 Dec 06

Efficacy and safety of avapritinib in advanced systemic mastocytosis: interim analysis of the phase 2 PATHFINDER trial.

Blood advances, 2023 May 09

Mast cell leukemia: clinical and molecular features and survival outcomes of patients in the ECNM Registry.

Blood advances, 2026 Jan 28

Efficacy and safety of avapritinib in advanced systemic mastocytosis: 4-year follow-up of the PATHFINDER study.

Related Topics in Internal Medicine